US SB3635 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 6-0)
Status: Introduced on May 6 2020 - 25% progression, died in committee
Action: 2020-05-06 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 6 2020 - 25% progression, died in committee
Action: 2020-05-06 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of, or reimbursement for, drugs manufactured in China, and for other purposes.
Title
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Sponsors
Sen. Tom Cotton [R-AR] | Sen. Marsha Blackburn [R-TN] | Sen. Ted Cruz [R-TX] | Sen. Steve Daines [R-MT] |
Sen. Rick Scott [R-FL] | Sen. Mike Braun [R-IN] |
History
Date | Chamber | Action |
---|---|---|
2020-05-06 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB6482 (Related) 2020-07-13 - Referred to the Subcommittee on Oversight and Investigations.
SB3537 (Related) 2020-03-19 - Read twice and referred to the Committee on Finance.
SB3537 (Related) 2020-03-19 - Read twice and referred to the Committee on Finance.
Subjects
Asia
Business expenses
China
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Health programs administration and funding
Health technology, devices, supplies
Income tax deductions
Manufacturing
Military medicine
Military procurement, research, weapons development
Prescription drugs
Public contracts and procurement
Trade restrictions
Veterans' medical care
Business expenses
China
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Health programs administration and funding
Health technology, devices, supplies
Income tax deductions
Manufacturing
Military medicine
Military procurement, research, weapons development
Prescription drugs
Public contracts and procurement
Trade restrictions
Veterans' medical care
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3635/all-info |
Text | https://www.congress.gov/116/bills/s3635/BILLS-116s3635is.pdf |